drugset / Trial / NCT00397722

Treatment Of Patients With Social Anxiety Disorder

NCT00397722

Phase 2 Completed 299 enrolled GlaxoSmithKline
RandomizedParallel-groupTreatment

Summary

GW876008 is a drug which may change mans reaction to stress, by decreasing the fear, physical and behavior symptoms that people with SocAD experience in social situations.

Timeline

Start
2006-11-09
Primary completion
2007-09-05
Completion
2007-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule
Subject Paroxetine Small molecule

Indications